| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Raloxifene |
Is a |
True |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Bisphosphonate (substance) |
Is a |
True |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Calcium regulating hormone (substance) |
Is a |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Parathyroid hormone agent |
Is a |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Product containing parathyroid hormone agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Calcium regulating agent adverse reaction |
Causative agent (attribute) |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Adverse reaction caused by bisphosphonate (disorder) |
Causative agent (attribute) |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Calcium regulating hormone adverse reaction |
Causative agent (attribute) |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Calcitonin adverse reaction |
Causative agent (attribute) |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Calcium regulating agent allergy |
Causative agent (attribute) |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Calcium regulating agent overdose |
Causative agent (attribute) |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Product containing bone resorption inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
1 |
| Product containing teriparatide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to parathyroid hormone and/or parathyroid hormone derivative |
Causative agent (attribute) |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to parathyroid and parathyroid derivatives NOS |
Causative agent (attribute) |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Teriparatide 250micrograms/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Substance with calcium-sensing receptor activator mechanism of action (substance) |
Is a |
True |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Strontium |
Is a |
True |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Calcitonin |
Is a |
True |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Product containing calcium regulating hormone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Calcitonin and salcatonin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to bone resorption inhibitor |
Causative agent (attribute) |
True |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
1 |
| Strontium ranelate (substance) |
Is a |
True |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Raloxifene hydrochloride (substance) |
Is a |
True |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
|
| Atypical fracture of femur (disorder) |
Causative agent (attribute) |
True |
Bone resorption inhibitor (substance) |
Inferred relationship |
Some |
1 |